CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Antithyroid drug therapy for Graves’ disease
Soo Myoung Shin, Ka Hee Yi
J Korean Med Assoc. 2021;64(10):690-698.   Published online October 10, 2021
DOI: https://doi.org/10.5124/jkma.2021.64.10.690

Excel Download

Antithyroid drug therapy for Graves’ disease
Journal of the Korean Medical Association. 2021;64(10):690-698   Crossref logo
Link1 Link2 Link3

The “GREAT” Score Predicts the Outcome of Antithyroid Drug Therapy of Graves’ Disease
Clinical Thyroidology. 2017;29(3):110-113   Crossref logo
Link1 Link2

Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves’ disease
Clinical Endocrinology. 2003;58(4):403-408   Crossref logo
Link1 Link2 Link3

Antithyroid drug treatment prior to radioiodine therapy for Graves’ disease: Yes or no?
Journal of Endocrinological Investigation. 2003;26(2):174-176   Crossref logo
Link1 Link2 Link3

Which antithyroid drug regimen in paediatric Graves' disease?
Clinical Endocrinology. 2012;77(6):806-807   Crossref logo
Link1 Link2

Antithyroid drug therapy for toxic diffuse goiter (Graves disease): Thirty years experience in children and adolescents
The Journal of Pediatrics. 1977;91(2):313-320   Crossref logo
Link1 Link2

MON-621 A Second Course of Antithyroid Drug Therapy Is Effective in Patients with Relapsed Graves' Disease
Journal of the Endocrine Society. 2019;3(Supplement_1):   Crossref logo
Link1

Predicting the Risk of Graves Disease Relapse: Commentary on “Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease”
Endocrine Practice. 2020;26(9):1039-1041   Crossref logo
Link1 Link2

Pancytopenia and Lymphoid Organ Hyperplasia in a Patient with Graves Disease: Response to Antithyroid Drug Therapy
AACE Clinical Case Reports. 2019;5(6):e388-e392   Crossref logo
Link1 Link2

A Validated Tool Can Predict Risk or Nonrisk of Graves’ Orbitopathy During Antithyroid Drug Treatment of Hyperthyroid Graves’ Disease
Clinical Thyroidology. 2018;30(6):246-250   Crossref logo
Link1 Link2